Institutional investors hold a majority ownership of MEIP through the 63.45% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended December 2014, these large investors purchased a net $8.6 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DEERFIELD MANAGEMENT CO. LP Bought 1.9 Million shares of MEI Pharma Inc
POINT72 ASSET MANAGEMENT LP Bought 1.7 Million shares of MEI Pharma Inc
FRANKLIN ADVISERS, INC. Bought 1.5 Million shares of MEI Pharma Inc